SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-331171
Filing Date
2013-08-12
Accepted
2013-08-12 17:24:51
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d546388d10q.htm 10-Q 310152
2 EX-31.1 d546388dex311.htm EX-31.1 6889
3 EX-31.2 d546388dex312.htm EX-31.2 6889
4 EX-32.1 d546388dex321.htm EX-32.1 5345
  Complete submission text file 0001193125-13-331171.txt   2850974

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxgn-20130630.xml EX-101.INS 185746
6 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20130630.xsd EX-101.SCH 20167
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20130630_cal.xml EX-101.CAL 24880
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20130630_def.xml EX-101.DEF 41253
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20130630_lab.xml EX-101.LAB 173611
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20130630_pre.xml EX-101.PRE 117177
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 131030615
SIC: 2836 Biological Products, (No Diagnostic Substances)